Matthew T Menard, Michael R Jaff, Alik Farber, Kenneth Rosenfield, Michael S Conte, Christopher J White, Joshua A Beckman, Niteesh K Choudhry, Leonardo C Clavijo, Thomas S Huber, Katherine R Tuttle, Taye H Hamza, Andres Schanzer, Igor A Laskowski, Mark J Cziraky, Alain Drooz, Max van Over, Michael B Strong, Ido Weinberg
OBJECTIVES: The use of optimal medical therapy (OMT) in patients with chronic limb-threatening ischemia (CLTI) has not been well-studied. The Best Endovascular vs Best Surgical Therapy in Patients with CLTI study (BEST-CLI) is a multicenter, randomized, controlled trial sponsored by the National Institutes of Health comparing revascularization strategies in patients with CLTI. We evaluated the use of guideline-based OMT among patients with CLTI at the time of their enrollment into the trial...
September 2023: Journal of Vascular Surgery